SecBot SecBot
EFFECT ·Filed Sep 16, 2026

ZSTK

ZeroStack Corp.
NEUTRAL
Impact 3/10
Horizonweeks Processed1mo ago SEC9999999995-26-002967
IPO/offering going effective
Actionable Insight • Neutral

Monitor for any subsequent prospectus supplement or takedown notice that would signal an actual offering. The shelf's activation is a prerequisite for future capital raises but does not itself trigger dilution. The cross-filing amplifier verdict suggests this event may be more closely watched by the market than a typical shelf effectiveness.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d
ZSTK ▲ +5.30% at T+20d
NEUTRAL call +5.30% · α vs SPY +2.12% · entry $4.15 → $4.37
Next anchor: T+60d in 6w
Latest observation: T+27 -21.56% FF3 residual α
Entry = T+0 close
Sep 16, 2026
via day close
T+1d
+8.43%
call +8.43% · α +7.30%
$4.50
settled 6w ago
T+5d
-5.54%
call -5.54% · α -8.11%
$3.92
settled 5w ago
T+20d
+5.30%
call +5.30% · α +2.12%
$4.37
settled 13d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

ZeroStack Corp. (ZSTK) received SEC effectiveness on September 15, 2026, for its shelf registration (File No. 333-296686) under the 1933 Act. This allows the company to sell securities at any time, creating a potential dilution overhang. The filing is routine for shelf effectiveness, but the cross-filing actuarial verdict flags this as an amplifier in an IPO context, suggesting heightened market sensitivity to the offering's activation.

Key Facts

  • Shelf registration (File No. 333-296686) declared effective on September 15, 2026.
  • ZeroStack Corp. (ZSTK) is classified under SIC 6199 (Finance Services) and formerly known as Flora Growth Corp.
  • The company can now issue securities at any time, introducing potential dilution risk.

Financial Impact

No specific offering size or pricing disclosed; dilution potential is contingent on future sales under the shelf.

dilution

Risk Factors

  • Potential future dilution if the company sells shares under the shelf.
  • No disclosure of intended use of proceeds or offering size, creating uncertainty.

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002967
Document: 9999999995-26-002967-index.html9999999995-26-002967
Document: 9999999995-26-002967.txt9999999995-26-002967
7 reports for ZSTK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ZSTK — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
SC 13G
NEUTRAL ★ 4/10
$3.71awaiting T+20—$3.13 (−15.63%)
Sep 16, 2026
5w ago
EFFECT
NEUTRAL ★ 3/10
$4.15 $4.37▲ +5.30%▲ +2.12%$3.13 (−24.58%)
Sep 3, 2026
7w ago
EFFECT
BEARISH ★ 6/10
$4.82 $4.86▼ −0.83%▼ −2.02%$3.13 (+35.06%)
Aug 19, 2026
9w ago
8-K
MIXED ★ 7/10
$4.96 $4.50▼ −9.27%▼ −7.32%$3.13 (−36.90%)
Jul 20, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$1.65 $1.84▲ +11.52%▲ +8.96%$3.13 (+89.70%)
Jun 18, 2026
18w ago
EFFECT
BEARISH ★ 6/10
$4.04 $1.87▲ +53.71%▲ +54.25%$3.13 (+22.52%)
Jun 10, 2026
19w ago
S-4
MIXED ★ 6/10
$4.89 $2.49▼ −49.06%▼ −50.95%$3.13 (−35.97%)
Showing 7 of 7

US Market Status

Market Open — Closes in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026